MehmetFevziOzkaynakMD

Pediatric Hematology & Oncology • Hawthorne, NY

Pediatric Solid Tumor Oncology

Professor of Pediatrics, New York Medical College

Join to view full profile

Dr. Ozkaynak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ozkaynak's full profile

Already have an account?

Office
19 Bradhurst Ave
Ste. 1400
Hawthorne, NY 10532
Phone+1 914-493-7997

Fax+1 914-594-4022
Is this information wrong?

Education & Training

Children's Hospital Los AngelesResidency, Pediatrics, 1989 - 1991
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 1986 - 1989
Hacettepe University FOMClass of 1978

Certifications & Licensure

CA State Medical License 1990 - Present
NY State Medical License 1994 - 2024
CT State Medical License 1997 - 2024
ME State Medical License Active through 2006
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2010-2014
Westchester Magazine: Top Doctors Castle Connolly, 2011

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Start of enrollment: 2004 Mar 15
Completed
Phase 3
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
Completed
Phase 3
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 25
Recruiting
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Start of enrollment: 2004 Apr 01
Active, not recruiting
Phase 3
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Start of enrollment: 2005 Nov 14
Completed
Phase 3
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission Start of enrollment: 2005 May 30
Completed
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer Start of enrollment: 2006 Feb 20
Completed
Phase 3
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor Start of enrollment: 2007 May 03
Completed
Phase 3
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant Start of enrollment: 2006 Apr 01
Completed
Phase 2
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Start of enrollment: 2006 Oct 30
Active, not recruiting
Phase 3
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Start of enrollment: 2006 Dec 26
Completed
Phase 3
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes Start of enrollment: 2007 Mar 01
Completed
Phase 3
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Start of enrollment: 2007 Feb 26
Active, not recruiting
Phase 3
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 3
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission Start of enrollment: 2007 Mar 01
Completed
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Start of enrollment: 2007 Jan 22
Active, not recruiting
Phase 3
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
Completed
Phase 3
Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases Start of enrollment: 2007 Dec 31
Completed
Phase 3
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin Start of enrollment: 2007 May 01
Completed
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma Start of enrollment: 2008 Feb 04
Active, not recruiting
Phase 3
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2008 Jan 15
Active, not recruiting
Phase 3
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2009 Jan 01
Completed
Phase 2
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2006 Sep 25
Completed
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma Start of enrollment: 2005 May 30
Completed
Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2009 Dec 21
Completed
Phase 3
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2011 Sep 01
Completed
Phase 2
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Start of enrollment: 2011 Sep 01
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
Completed
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 2012 Feb 21
Active, not recruiting
Phase 3
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Start of enrollment: 2012 Jun 27
Active, not recruiting
Phase 2
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Start of enrollment: 2013 Nov 04
Completed
Phase 3
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24
Completed
Phase 2
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. Start of enrollment: 2013 Aug 20
Completed
Phase 2
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Active, not recruiting
Phase 2
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

7 citations
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group.
Ami V Desai, Andrew L Gilman, Mehmet Fevzi Ozkaynak, Arlene Naranjo, Wendy B London, Sheena C Tenney, Mitchell Diccianni, Jacquelyn A Hank, Marguerite T Parisi, Barry ...> ;Journal of Clinical Oncology. 2022 Dec 10
78 citations
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.
Alice L. Yu, Andrew L. Gilman, M. Fevzi Ozkaynak, Arlene Naranjo, Mitchell B. Diccianni, Jacek Gan, Jacquelyn A. Hank, Ayse Batova, Wendy B. London, Sheena C. Tenney, ...> ;Clinical Cancer Research. 2021 Apr 15
2 citations
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disorders.
Nabanita Bhunia, Rolla Abu-Arja, Joseph R. Stanek, Lubna S Mehyar, Peter J. Shaw, Hyoung Jin Kang, Jerry Stein, Tracey A. O'Brien, Catherine H. Roberts, Acw Lee, David...> ;Transfusion. 2021 Jan 21
4 citations
The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transpla...
Jessica Hochberg, Stacey Zahler, Mark B. Geyer, Nan Chen, Jennifer Krajewski, Lauren Harrison, O. Militano, M. Fevzi Ozkaynak, Alexandra Cheerva, Julie Talano, Theodor...> ;Bone Marrow Transplantation. 2019 Feb 1
23 citations
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal F...
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Biology of Blood and Marrow Transplantation. 2018 Oct 1
4 citations
Mycophenolate mofetil administered every 8 hours in combination with tacrolimus is efficacious in the prophylaxis of acute graft versus host disease in childhood, adol...
Olga Militano, M. F. Ozkaynak, Brinda Mehta, Carmella van deVen, Carl V. Hamby, Mitchell S. Cairo> ;Pediatric Blood & Cancer. 2018 Aug 1
Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Th...
Ozkaynak, M. F.,Gilman, A. L.,London, W. B.,Naranjo, A.,Diccianni, M. B.,Tenney, S. C.,Smith, M.,Messer, K. S.,Seeger, R.,Reynolds, C. P.,Smith, L. M.,Shulkin, B. L.,P...> ;Front Immunol. 2018 Jul 27
A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Childr...
Ozkaynak, M. F.,Gilman, A. L.,London, W. B.,Naranjo, A.,Diccianni, M. B.,Tenney, S. C.,Smith, M.,Messer, K. S.,Seeger, R.,Reynolds, C. P.,Smith, L. M.,Shulkin, B. L.,P...> ;Front Immunol. 2018 Jul 04
40 citations
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.
Amy K. Erbe, Wei Wang, Lakeesha Carmichael, KyungMann Kim, Eneida A. Mendonça, Yiqiang Song, Dustin Hess, Patrick K. Reville, Wendy B. London, Arlene Naranjo, Jacquely...> ;Clinical Cancer Research. 2018 Jan 1
14 citations
HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy.
Amy K. Erbe, Wei Wang, Patrick K. Reville, Lakeesha Carmichael, Kyung Mann Kim, Eneida A. Mendonça, Yiqiang Song, Jacquelyn A. Hank, Wendy B. London, Arlene Naranjo, F...> ;Frontiers in Immunology. 2017 Jun 12
5 citations
Laparoscopic Surgery for Acute Appendicitis in Children With Cancer.
Julia Singer, Gustavo Stringel, M. F. Ozkaynak, Whitney McBride, Samir Pandya, Claudio Sandoval> ;JSLS. 2015 Jul 1
8 citations
Acquired thrombotic thrombocytopenic purpura in children: a single institution experience.
Somasundaram Jayabose, Theodore S. Nowicki, Julie Dunbar, Oya Levendoglu-Tugal, M. F. Ozkaynak, Claudio Sandoval> ;Indian Journal of Pediatrics. 2013 Jul 1
5 citations
Osteosarcoma Following Growth Hormone Therapy in Recurrent Acute Lymphoblastic Leukemia and Rapadilino Syndrome
Claudio Sandoval, Julie Dunbar, M. F. Ozkaynak, Somasundaram Jayabose> ;Pediatric Hematology and Oncology. 2012 Apr 4
14 citations
Rituximab therapy to prevent relapse in chronic relapsing thrombotic thrombocytopenic purpura (TTP) in a child.
Somasundaram Jayabose, Julie Dunbar, Theodore S. Nowicki, Oya Tugal, M. F. Ozkaynak, Claudio Sandoval> ;Pediatric Hematology and Oncology. 2011 Feb 7
11 citations
Favorable outcome of primary CNS anaplastic large cell lymphoma in an immunocompetent patient.
M. F. Ozkaynak> ;Journal of Pediatric Hematology/oncology. 2009 Feb 1
103 citations
Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplant...
Andrew L. Gilman, M. Fevzi Ozkaynak, Katherine K. Matthay, Mark Krailo, Alice L. Yu, Jacek Gan, Adam Sternberg, Jacquelyn A. Hank, Robert C. Seeger, Gregory H. Reaman,...> ;Journal of Clinical Oncology. 2009 Jan 1
4 citations
A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric...
M. Fevzi Ozkaynak, Indira Sahdev, Thomas G. Gross, John E. Levine, Alexandra Cheerva, Michael Richards, Marta K. Rozans, Peter J. Shaw, Richard Kadota> ;Journal of Pediatric Hematology/oncology. 2008 Mar 1
7 citations
Cleft palate, bilateral external auditory canal atresia, and other midline defects associated with Diamond-Blackfan anemia: case report.
Alicia McFarren, Somasundaram Jayabose, M. F. Ozkaynak, Oya Tugal, Claudio Sandoval> ;Journal of Pediatric Hematology/oncology. 2007 May 1
Neuroblastoma masquerading as cervical lymphadenitis.
Stephanie Pepper, Humayun K. Islam, Somasundarm Jayabose, M. F. Ozkaynak, Oya Tugal, Claudio Sandoval> ;Journal of Pediatric Hematology/oncology. 2007 Apr 1
7 citations
Recurrent immune thrombocytopenic purpura in children.
Somasundaram Jayabose, Oya Levendoglu-Tugal, M. F. Ozkaynak, Claudio Sandoval> ;Pediatric Hematology and Oncology. 2006 Dec 1
8 citations
A pilot trial of tandem autologous peripheral blood progenitor cell transplantation following high-dose thiotepa and carboplatin in children with poor-risk central ner...
M. Fevzi Ozkaynak, Claudio Sandoval, Oya Levendoglu-Tugal, Somasundaram Jayabose> ;Pediatric Hematology and Oncology. 2004 Oct 1
7 citations
Gemcitabine and vinorelbine as a salvage regimen for relapse in Hodgkin lymphoma after autologous hematopoietic stem cell transplantation.
M. Fevzi Ozkaynak, Somasundaram Jayabose> ;Pediatric Hematology and Oncology. 2004 Mar 1
10 citations
Real-Time Quantitative PCR: Standardized Detection of Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia
Sharon R. Pine, Fred H Moy, Joseph L. Wiemels, Ramneet K Gill, Oya Levendoglu-Tugal, M. F. Ozkaynak, Claudio Sandoval, Somasundaram Jayabose> ;Journal of Pediatric Hematology/oncology. 2003 Feb 1
23 citations
Hemophagocytic lymphohistiocytosis presenting with thrombocytopenia in the newborn
Oya Levendoglu-Tugal, M. Fevzi Ozkaynak, Edmund F. LaGamma, Ariel Sherbany, Claudio Sandoval, Somasundaram Jayabose> ;Journal of Pediatric Hematology/oncology. 2002 Jun 1
13 citations
Quantitation of leukemia clone-specific antigen gene rearrangements by a single-step PCR and fluorescence-based detection method.
Sharon P. Mayer, J. Giamelli, Claudio Sandoval, A. S. Roach, M. Fevzi Ozkaynak, Oya Tugal, G Rovera, Somasundaram Jayabose> ;Leukemia. 1999 Nov 1
Join now to see all

Journal Articles

The Safety and Efficacy of Clofarabine in Combination with High-Dose Cytarabine and Total Body Irradiation Myeloablative Conditioning and Allogeneic Stem Cell Transpla...
Stacey Zahler, Mitchell S Cairo, Jennifer Krajewski, M Fevzi Ozkaynak, Alexandra C Cheerva, Theodore B Moore, Alfred P Gillio, Mark C Walters, Nature

Hospital Affiliations

Westchester Medical CenterValhalla, New York
Vassar Brothers Medical CenterPoughkeepsie, New York